| |
Controls n=425a |
DCM n=442b |
| Gender |
| Male |
45 % |
82% |
| Female |
55 % |
18 % |
| Age (y) |
61 ± 11 |
53 ± 12 (n=439) |
| Heart rate (beats/min) |
67 ± 11 (n=321) |
74 ± 16 (n=351) |
| Systolic blood pressure (mmHg) |
138 ± 18 (n=321) |
125 ± 23 (n=364) |
| EF (%) |
Not applicable |
31 ± 15 (n=381) |
| NYHA class (I:II:III:IV) |
Not available |
69:123:155:15 (n=362) |
| β-Blockers |
8 % (n=321) |
66 % (n=365) |
| ACE inhibitors |
Not available |
69 % ( n=365) |
EF: Ejection fraction; ACE: Angiotensin-converting enzyme. an=424 for MHC2TA; bn=440 for IFN-γ |
